THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 121 filers reported holding THERAVANCE INC in Q3 2015. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $208,860,000 | +46.8% | 19,815,983 | 0.0% | 3.79% | +59.8% |
| Q3 2015 | $142,279,000 | -60.3% | 19,815,983 | 0.0% | 2.37% | -60.3% |
| Q2 2015 | $358,075,000 | +14.9% | 19,815,983 | 0.0% | 5.97% | +14.0% |
| Q1 2015 | $311,507,000 | +11.1% | 19,815,983 | 0.0% | 5.23% | -5.0% |
| Q4 2014 | $280,396,000 | -17.2% | 19,815,983 | 0.0% | 5.51% | -6.6% |
| Q3 2014 | $338,655,000 | -44.2% | 19,815,983 | -2.8% | 5.90% | -40.4% |
| Q2 2014 | $607,365,000 | -5.2% | 20,395,056 | -1.5% | 9.89% | -36.1% |
| Q1 2014 | $640,637,000 | -10.8% | 20,705,801 | +2.8% | 15.48% | -23.9% |
| Q4 2013 | $718,144,000 | -5.1% | 20,144,301 | +8.8% | 20.35% | -5.9% |
| Q3 2013 | $756,519,000 | +18.7% | 18,510,371 | +11.9% | 21.62% | +36.5% |
| Q2 2013 | $637,247,000 | – | 16,538,977 | – | 15.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,341,000 | $14,727,000 | 5.03% |
| Baupost Group | 19,815,983 | $142,279,000 | 2.37% |
| Litespeed Management, L.L.C. | 2,670,695 | $19,176,000 | 2.36% |
| Clearline Capital LP | 1,147,741 | $8,241,000 | 1.39% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,830,301 | $20,322,000 | 1.06% |
| Empyrean Capital Partners, LP | 2,742,302 | $19,690,000 | 0.97% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 12,510,283 | $89,824,000 | 0.76% |
| PERRY CAPITAL | 2,503,600 | $17,976,000 | 0.71% |
| Roundview Capital LLC | 210,186 | $1,509,000 | 0.65% |
| Kamunting Street Capital Management, L.P. | 30,574 | $220,000 | 0.55% |